Vancomycin-resistant enterococci (VRE) and methicillin-oxacillin-resistant
Staphylococcus aureus (MRSA) originally predominated in large medical cente
rs; however, these isolates are now common in community hospitals and commu
nity clinics. No simple answer is available regarding control of antimicrob
ial-resistant bacteria, especially VRE and MRSA, as their numbers increase
and pose a more serious threat to patient care. The source of colonization
is often difficult to identify because of transport of patients among diffe
rent locations on the continuum of care (e.g., hospital to extended care fa
cility to home and back). At one hospital, control strategies greatly reduc
ed the occurrence of gram-negative bacteria such as VRE. Since 1994, VRE de
clined from 16% to 5%. Similarly, the number of MRSA isolates declined from
35% to 23%. These declines are attributed to a cohesive working relationsh
ip among pharmacists, microbiologists, and infectious disease physicians an
d personnel, and to a decision to decrease administration of cephalosporins
in favor of piperacillin-tazobactam.